Resource Center
Discovering & Developing Next Generation Diagnostic Tools for the Early Detection of TA-TMA
Dr. Anthony Sabulski, a leading physician and researcher of TA-TMA in HSCT patients, has been involved in essential research to identify patients at risk for this complication and to implement early interventions to improve TA-TMA associated transplant outcomes. View this interactive webinar highlighting the latest research and case studies of the clinical usage of this diagnostic tool aimed at improving the lives of post-transplant patients. Followed by a Q&A Session.
Please complete the form to access this resource.
Featured Resource
Immunity Testing: CMV in Lung Transplant Patients
This bi-lateral lung transplant recipient is a 65 year-old male patient who received his lung transplant due to end-stage lung disease secondary to non-CF bronchiectasis. The donor and recipient CMV serostatus is D+/R+. The patient’s initial peri-operative course was complicated by difficult explant, primary graft dysfunction, respiratory failure requiring prolonged mechanical ventilation, renal insufficiency and recurrent infectious concerns, including pseudomonas and stenotrophomonas pneumonias.
Search the Eurofins Viracor online test directory
for the most up-to-date assay offerings and information
Test Menu